Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of Naoluoshu Ning granules in mild-to-moderate vascular dementia
CTR20231318Phase 2Active
- Sponsor
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
- Start
- Apr 2023
- Countries
- 1
01
Overview
A Phase 2 trial of naoluoshu ning granules in vascular dementia, sponsored by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences. Started Apr 2023; status: active.
02
Drugs
naoluoshu ning granules
03
Conditions
vascular dementia
Beyond the preview
Go deeper on CTR20231318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231318.